An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 9 August 2012.
Opposition Proceedings
Opposition Lodged
Acceptance of the following patent applications has been opposed as at 9 August 2012:
Application No. |
Applicant(s) |
Opponent(s) |
2008205451 | Koppers Arch Wood Protection (Aust) Pty Limited | Osmose (Australia) Pty Limited |
2010201144 | Azuma Design Pty Limited | Pacific Enterprises (Aust) Pty Ltd |
Opposition Withdrawn
Opposition to acceptance of the following applications has been withdrawn as at 9 August 2012, and the application shall proceed to sealing:
Application No. |
Applicant(s) |
Opponent(s) |
2006241345 | Biosigma S.A | BHP Billiton SA Limited |
Opposition Dismissed
No additional opposition proceedings have been dismissed as at 9 August 2012.
Applications Withdrawn
No additional applications have been withdrawn following opposition as at 9 August 2012.
Extensions of Term of Standard Patents
Applications Filed
The following application(s) for Extension of Term under Section 70 have been made as at 9 August 2012:
Patent No. |
Patentee(s) | Goods & First Reg. Approval |
Novartis AG | RASILAMLO HCT; 12 June 2012 |
Applications Accepted
No additional application(s) for Extension of Term have been accepted as at 9 August 2012.
Â
Surrendered and Revoked Letters Patent
Surrendered Letters Patent
The following patents have been offered for surrender as at 9 August 2012:
Patent No. |
Patentee(s) |
Date of Patent |
Title |
2003271740 | Janssen R&D Ireland | 26 August 2010 | Pseudopolymorphic forms of a HIV protease inhibitor |
2004262901 | Boehringer Ingelheim International | 26 August 2010 | Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation |
2004262902 | Boehringer Ingelheim International | 12 November 2009 | Medicaments for inhalation comprising betamimetics and an anticholinergic |
Revocation of Letters Patent
No additional patents have been revoked as at 9 August 2012.